In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications

By Dansereau Richard J.   Crail Debbie J.   Perkins Alan C.  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite

In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada

By Walker A.D.   Adachi J.D.  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1749-1754

Informa Healthcare

Access to resources Recommend Favorite

Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies

By Liu Dongfei   Ge Yifan   Tang Yue   Yuan Yubing   Zhang Qing   Li Rui   Xu Qunwei  

Journal of Microencapsulation, Vol. 27, Iss. 8, 2010-12 ,pp. : 726-734

Informa Healthcare

Access to resources Recommend Favorite

Simvastatin nanoemulsion for improved oral delivery: design, characterisation, in vitro and in vivo studies

By Chavhan Sandip S.   Petkar Kailash C.   Sawant Krutika K.  

Journal of Microencapsulation, Vol. 30, Iss. 8, 2013-12 ,pp. : 771-779

Informa Healthcare

Access to resources Recommend Favorite

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

By Sebba Anthony I.   Bonnick Sydney Lou   Kagan Risa   Thompson Desmond E.   Skalky Carol S.   Chen Erluo   de Papp Anne E.    

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2031-2041

Informa Healthcare

Access to resources Recommend Favorite